Want to join the conversation?
$HALO 2Q15 Call: Royalty revenue grew YoverY approx. 278% to $6.4MM in 2Q15 reflecting partnered product sales in the Jan. to March 2015 period. The key driven has been has been the increasing sales of Herceptin SC. On a sequential basis, we saw decline of $400,000 in Royalty revenue due to some initial stockings of HYQVIA.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?